Mind Medicine (MindMed) Inc. Common Shares
Symbol: MNMD (NASDAQ)
Company Description:
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
- Today's Open: $11.658
- Today's High: $11.73
- Today's Low: $11.45
- Today's Volume: 25.81K
- Yesterday Close: $11.79
- Yesterday High: $12
- Yesterday Low: $11.1723
- Yesterday Volume: 2.54M
- Last Min Volume: 138
- Last Min High: $11.66
- Last Min Low: $11.66
- Last Min VWAP: $11.66
- Name: Mind Medicine (MindMed) Inc. Common Shares
- Website: https://www.mindmed.co
- Listed Date: 2020-03-03
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0001813814
- SIC Code: 2833
- SIC description: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
- Market Cap: $897.08M
- Round Lot: 100
- Outstanding Shares: 76.09M
- Asset Type: CS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-26 | 4 | View |
| 2025-09-26 | 4 | View |
| 2025-09-26 | 4 | View |
| 2025-09-25 | 144 | View |
| 2025-09-25 | 144 | View |
| 2025-09-25 | 144 | View |
| 2025-09-04 | 8-K | View |
| 2025-07-31 | 10-Q | View |
| 2025-07-31 | 8-K | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-25 | 144 | View |
| 2025-06-25 | 144 | View |
| 2025-06-25 | 144 | View |
| 2025-06-20 | S-8 | View |
| 2025-06-16 | 8-K | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |